Masaru Miura

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial

Tohru Kobayashi, Tsutomu Saji, Tetsuya Otani et al. · The Lancet · 2012 · 656 citations

Percutaneous Coronary Intervention, Severe Kawasaki Disease, Cardiovascular Disease +8

Revision of diagnostic guidelines for Kawasaki disease (6th revised edition)

Tohru Kobayashi, Mamoru Ayusawa, Hiroyuki Suzuki et al. · Pediatrics International · 2020 · 584 citations

Clinical Epidemiology, Diagnosis, Pathology +3

A New Z Score Curve of the Coronary Arterial Internal Diameter Using the Lambda-Mu-Sigma Method in a Pediatric Population

Tohru Kobayashi, Shigeto Fuse, Naoko Sakamoto et al. · Journal of the American Society of Echocardiography · 2016 · 240 citations

Heart Failure, Cardiovascular Disease, Pediatric Heart Disease +11

Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events

Masaru Miura, Tohru Kobayashi, Tetsuji Kaneko et al. · JAMA Pediatrics · 2018 · 141 citations · Full text

Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study

Koichi Miyata, Tetsuji Kaneko, Yoshihiko Morikawa et al. · The Lancet Child & Adolescent Health · 2018 · 94 citations

Rheumatology, Post Raise, Autoimmune Disease +7